Figure 2
Figure 2. Clinical and laboratory parameters of index case (patient A). Body temperature and laboratory parameters included in the diagnostic criteria for hemophagocytic lymphohistiocytosis (HLH) according to the Histiocyte Society (panels 1-5) and liver parameters (panel 6) are charted for the first 50 days after admission. Black lines indicate tonsillectomy, treatment with rituximab (day 20, 412 mg/m2), and 2 doses of etoposide (days 26 and 33, 100 mg/m2). The shaded area represents days with administrated intravenous immunoglobulin (IVIG; day 17 and days 19-22; 0.17 g/kg and 0.40 g/kg per day, respectively).

Clinical and laboratory parameters of index case (patient A). Body temperature and laboratory parameters included in the diagnostic criteria for hemophagocytic lymphohistiocytosis (HLH) according to the Histiocyte Society (panels 1-5) and liver parameters (panel 6) are charted for the first 50 days after admission. Black lines indicate tonsillectomy, treatment with rituximab (day 20, 412 mg/m2), and 2 doses of etoposide (days 26 and 33, 100 mg/m2). The shaded area represents days with administrated intravenous immunoglobulin (IVIG; day 17 and days 19-22; 0.17 g/kg and 0.40 g/kg per day, respectively).

or Create an Account

Close Modal
Close Modal